Question 45

Researchers should use functional magnetic resonance imaging (fMRI) to evaluate the drug's effect on brain activity.

Functional magnetic resonance imaging (fMRI) is a non-invasive imaging technique that measures and maps brain activity by detecting changes in blood flow, making it ideal for evaluating the effects of an antidepressant on brain function.

A) Blood tests for hormone levels

Blood tests for hormone levels may provide some insight into hormonal changes related to mood disorders, but they do not directly measure brain activity. Therefore, they are not suitable for assessing the specific effects of an antidepressant on brain function.

B) Functional magnetic resonance imaging (fMRI)

Functional magnetic resonance imaging (fMRI) is the most appropriate choice because it directly visualizes brain activity by measuring changes in blood flow associated with neural activity. This allows researchers to observe how the new antidepressant influences brain function in real-time.

C) White blood cell count

White blood cell count is a measure of immune system function and is not related to brain activity. While it can indicate inflammation or infection, it does not provide any information regarding the effects of an antidepressant on the brain.

D) Electrolyte panel

An electrolyte panel assesses the balance of minerals in the body, such as sodium and potassium, which are important for various physiological functions. However, it does not evaluate brain activity and is not relevant for testing the effects of antidepressants on brain function.

Conclusion

Functional magnetic resonance imaging (fMRI) stands out as the only option that effectively measures brain activity, making it the definitive choice for evaluating the impact of the new antidepressant. In contrast, the other options do not provide insights into brain function, thus failing to meet the requirements of the clinical trial.